Dr Debra Peattie is Senior Director in the Future Pipelines Discovery division of GlaxoSmithKline. A veteran life science entrepreneur, Dr Peattie concentrates on translating early-stage science into novel therapeutics within GSK’s Discovery Partnerships with Academia initiative. Prior to joining GSK in 2013, Dr Peattie spent time in the Office of Technology Development at Harvard University and in Strategy & Planning at Cubist Pharmaceuticals; she also consulted independently for several years to emerging life science companies. Earlier in her career, she was a founding member of MPM Capital and a founding scientist at Vertex Pharmaceuticals.
Dr Peattie holds an MBA from Harvard Business School and PhD in Biochemistry & Molecular Biology from Harvard University. She has served on biotechnology company boards and has published extensively in peer-reviewed journals. Dr Peattie currently holds board positions within Harvard Business School and the Faculty of Arts and Sciences at Harvard University.